Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vella

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
AIDS Clinical Care|August 13, 2002
Structured treatment interruptions and treatment intensificationS Vella
AIDS Clinical Care|May 22, 2001
Advances in the virology of HIV infections and implications for clinical managementS Vella
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV pathogenesis and treatment strategiesS Vella
Journal of the International Association of Physicians in AIDS Care|December 1, 1995
Protease inhibitors and nucleosides: how many? when? An interview with Stefano Vella, MD. Interview by Mark MascoliniS Vella
AIDS Clinical Care|October 1, 1996
New antiretroviral therapy guidelinesS Vella
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Rationale and experience with reverse transcriptase inhibitors and protease inhibitorsS Vella
AIDS (London, England)|December 1, 1995
Clinical experience with saquinavirS Vella
AIDS Clinical Care|May 1, 1995
Immunological and virological markers in HIV infectionS Vella
AIDS Clinical Care|October 1, 1995
Update on HIV protease inhibitorsS Vella
AIDS Clinical Care|June 1, 1997
Clinical implications of resistance to antiretroviral drugsS Vella
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
AIDS Clinical Care|August 13, 2002
Structured treatment interruptions and treatment intensificationS Vella
AIDS Clinical Care|May 22, 2001
Advances in the virology of HIV infections and implications for clinical managementS Vella
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV pathogenesis and treatment strategiesS Vella
Journal of the International Association of Physicians in AIDS Care|December 1, 1995
Protease inhibitors and nucleosides: how many? when? An interview with Stefano Vella, MD. Interview by Mark MascoliniS Vella
AIDS Clinical Care|October 1, 1996
New antiretroviral therapy guidelinesS Vella
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Rationale and experience with reverse transcriptase inhibitors and protease inhibitorsS Vella
AIDS (London, England)|December 1, 1995
Clinical experience with saquinavirS Vella
AIDS Clinical Care|May 1, 1995
Immunological and virological markers in HIV infectionS Vella
AIDS Clinical Care|October 1, 1995
Update on HIV protease inhibitorsS Vella
AIDS Clinical Care|June 1, 1997
Clinical implications of resistance to antiretroviral drugsS Vella
Pageof 17